Clinical Trial

Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms

Study acronym: PREPHAGE
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated November 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture) (ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection) (iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06524791
Lead Sponsor Central Hospital, Nancy, France
Conditions Gastroenteritis
Enrollment 300 participants
Start Date 2024-11-15
Primary Completion 2024-11-15 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2024-07-30